First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors.
Wei XL, Liu FR, Liu JH, Zhao HY, Zhang Y, Wang ZQ, Qiu MZ, Xu F, Yu QQ, Du YW, Shi YX, Wang DS, Wang FH, Xu RH.
Wei XL, et al. Among authors: zhang y.
Nat Commun. 2022 Nov 16;13(1):7012. doi: 10.1038/s41467-022-34782-9.
Nat Commun. 2022.
PMID: 36385120
Free PMC article.
Clinical Trial.